Terns Pharmaceuticals
TERN
TERN
36 hedge funds and large institutions have $204M invested in Terns Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.65M | |
| 2 | +$736K | |
| 3 | +$371K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$369K |
| 5 |
Morgan Stanley
New York
|
+$329K |
Top Sellers
| 1 | -$8.8M | |
| 2 | -$7.24M | |
| 3 | -$4.05M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.96M |